Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Axcella Health Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 30 | 15 | −15 |
| SharesConverted for a 1-for-25 split | 1.92M | 1.64M | −275.8K (−14.4%) |
| Value | $10.5M | $17.1M | +$6.68M (+63.8%) |
New holders (1)
Institutions that held Axcella Health Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 100,600 | $1.05M | 0.01% |
Sold out (16)
Institutions that held Axcella Health Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 200,409 | $43.7K |
| Edgewood Management LLC | 100,000 | $21.8K |
| State Street Corp | 77,272 | $16.9K |
| Millennium Management LLC | 72,281 | $15.8K |
| Northern Trust Corp | 51,187 | $11.2K |
| Thrivent Financial for Lutherans | 44,000 | $11.0K |
| Virtu Financial LLC | 44,716 | $10.0K |
| Bank of New York Mellon Corp | 43,572 | $9.51K |
| Caas Capital Management LP | 37,305 | $8.14K |
| Charles Schwab Investment Management Inc | 18,250 | $3.98K |
| Renaissance Technologies LLC | 13,000 | $3.00K |
| TownSquare Capital, LLC | 11,950 | $2.61K |
| Portside Wealth Group, LLC | 11,950 | $2.61K |
| Group One Trading, L.P. | 400 | $87 |
| Advisor Group Holdings, Inc. | 10 | $2 |
| Simplex Trading, LLC | 1,541 | $0 |